PPARA and idiopathic pulmonary fibrosis: This was accompanied by changes in peroxisomal lipid metabolism, e.g. TGF-β1 increased the level of phosphatidylcholine in control, but decreased it in IPF fibroblasts with no additional effects of the PPAR drugs.